What are the benefits and risks of drugs acting on the immune system to treat relapsing-remitting multiple sclerosis ?
3/5/2024
0:00
4:43
There are more than 60 Cochrane Reviews relevant to multiple sclerosis and, one of these, a network meta-analysis of immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis, was updated in January 2024. We asked the lead author, Francesco Nonino from the Institute of Neurological Science in Bologna, Italy, to tell us more about the condition and the latest evidence in this podcast.
More episodes from "Cochrane Library Podcasts"
Don't miss an episode of “Cochrane Library Podcasts” and subscribe to it in the GetPodcast app.